CD19 and neoplasm: The differentiated WT-iNK-like cells from WT-NK/iPSCs, even without anti-CD19 CAR, demonstrated an anti-tumor activity against certain tested tumor cells, likely because NK cells may target tumor cells in an antigen-unrestricted manner [31,32].